Mineralys Therapeutics
Mineralys Therapeutics is a small Molecules founded in 2020 by BT Slingsby.
1
Funding Rounds
$118.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| BT Sl****** | - | - | - |
Funding series
Funding Series Analysis
The company Mineralys Therapeutics has raised a total of $118m in funding over 1 rounds.
Key Insights:
- Mineralys Therapeutics Series B round, June 2022: $118m
Mineralys Therapeutics Series B round, June 2022
$118m
Industries
Mineralys Therapeutics is active in the following industries:
- Biomedical engineering
- Cardiology
- Internal medicine
- Healthcare
- Medicine
- Drug discovery
- Engineering